Chun Cai

Dr. Chun Cai


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2015 in Nutrition and Cancer
Verified
Journal Article
Closed access
QHQionglin Huang
Qionglin Huang
JWJuan Wen
Juan Wen
GCGuangzhao Chen
Guangzhao Chen
MGMiaomiao Ge
Miaomiao Ge
YGYihua Gao
Yihua Gao
CCChun Cai
Chun Cai
Omge-3 polyunsaturated fatty acids (PUFAs) exhibited significant effect in inhibiting various tumors. However, the mechanisms of its anticancer role have not been fully demonstrated. The declination of 5-methylcytosine (5 mC) was closely associated with poor prognosis of tumors. To explore whether omega-3 PUFAs influences on DNA methylation level in tumors, colorectal cancer (CRC) rat model were constructed using N-methyl phosphite nitrourea and omega-3 PUFAs were fed to part of the rats during tumor induction. The PUFAs contents in the rats of 3 experimental groups were measured using gas chromatography and 5 mC level were detected by liquid chromatography tandem mass spectrometry. The results showed that tumor incidence in omega-3 treated rats was much lower than in CRC model rats, which confirmed significant antitumor role of omega-3 PUFAs. Six PUFA members categorized to omega-3 and omega-6 families were quantified and the ratio of omega-6/omega-3 PUFAs was remarkably lower in omega-3 PUFAs treatment group than in CRC model group. 5 mC content in omega-3 PUFAs treated rats was higher than in CRC model rats, suggesting omega-3 PUFAs promoted 5 mC synthesis. Therefore, omega-3 PUFAs probably inhibited tumor growth via regulating DNA methylation process, which provided a novel anticancer mechanism of omega-3 PUFAs from epigenetic view.

1 August 2012 in SLAS Discovery
Verified
Journal Article
Open access
LZLiangtao Zhang
Liangtao Zhang
LZLijian Zhang
Lijian Zhang
KZKeyuan Zhou
Keyuan Zhou
XYXiaoxia Ye
Xiaoxia Ye
JZJunjie Zhang
Junjie Zhang
CCChun Cai
Chun Cai
Methylation of DNA at the 5-position of cytosine (Cyt) is a well-studied epigenetic pathway implicated in gene silencing and embryogenesis. Recently, in addition to 5-methylcytosine (5mC), substantial amounts of 5-hydroxymethylcytosine (5hmC) have been detected in certain mammalian tissues. Here, we developed and validated a hydrophilic interaction liquid chromatography–tandem mass spectrometry (HILIC-MS/MS) method for the simultaneous determination of Cyt, 5mC, and 5hmC levels in biological samples. DNA was extracted with phenol-chloroform, hydrolyzed using 88% formic acid at 140 °C, separated using a bridged ethylene hybrid HILIC column, and analyzed by tandem MS. The linearity was established over the concentration range of 1 to 500 ng/mL for Cyt, 0.2 to 100 ng/mL for 5mC, and 0.1 to 50 ng/mL for 5hmC, and the correlation coefficients were all >0.99. Limits of detection were 1 pg/mL for Cyt, 45 pg/mL for 5mC, and 57 pg/mL for 5hmC, and the limit of quantification values for Cyt, 5mC, and 5hmC were 2 pg/mL, 90 pg/mL, and 100 pg/mL, respectively. The relative standard deviation (RSD) of the intraday precision ranged from 1.87% to 4.84% and the interday precision from 2.69% to 4.98%. The recovery of the method varied from 88.25% to 104.39%. The method was then applied to the analysis of DNA from biological samples, establishing its potential for helping researchers understand the roles of modified nucleobases in DNA.

1 May 2017 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
LZLi-Jian Zhang
Li-Jian Zhang
BCBin Chen
Bin Chen
JZJun-Jie Zhang
Jun-Jie Zhang
JLJian Li
Jian Li
QYQingjing Yang
Qingjing Yang
CCChun Cai
Chun Cai

1 January 2021 in Talanta
Verified
Journal Article
Closed access
JZJunjie Zhang
Junjie Zhang
XSXianwei Su
Xianwei Su
AQAo Qi
Ao Qi
LLLulu Liu
Lulu Liu
LZLijian Zhang
Lijian Zhang
CCChun Cai
Chun Cai

14 August 2021 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
JZJunjie Zhang
Junjie Zhang
LLLulu Liu
Lulu Liu
LZLijiang Zhang
Lijiang Zhang
SCSimei Chen
Simei Chen
YCYusen Chen
Yusen Chen
CCChun Cai
Chun Cai

1 January 2006 in Journal of Drug Targeting
Verified
Journal Article
Closed access
CCChun Cai
Chun Cai
KZKeyuan Zhou
Keyuan Zhou
YWYong Wu
Yong Wu
LWLinyan Wu
Linyan Wu
The objective of this study was to develop a liver-specific antihepatocarcinoma agent. The galactosylated human serum albumin 5-fluorouracil conjugate (GHSA-5-FU) was prepared and tested for its chemical characteristic, biodistribution and primary cytotoxicity. The matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was applied to determined the molar ratio (moles of 5-FU/mole of G-HSA and moles of galactose/mole of HSA) of the conjugate. The liver targeting ability of GHSA-5-FU labeled by 131I was evaluated by measuring the total radioactivity in organs after i.v. administration in mice and rabbits, and the cytotoxicity of the conjugate was assayed by MTT method. The results showed that the molar ratio of galactose to HSA was 50, and the 5-FU to GHSA was 15. Liver uptake in rabbits and mice peaked within 5–20 min after injection. The radioactivity (counts/g tissue) of the conjugate in the liver was several times higher than those in the other organs. The conjugate showed strong cytotoxicity, but no significant cytotoxicity difference was found between GHSA-5-FU and free 5-FU.